Harvard Bioscience, Inc. HBIO
NASDAQ · United States · Health Technology
$8.34+0.21 (+2.58%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.14 | -0.21 | +33.3% | $22.73M | +6.0% | -3.4%$6.39→$6.17 |
| Q1 2026 | 2026-05-12 | -0.77 | -0.95 | +18.9% | — | — | -18.6%$6.84→$5.57 |
| Q4 2024 | 2025-03-12 | 0.60 | 0.50 | +20.0% | — | — | — |
| Q4 2023 | 2024-03-07 | 0.40 | 0.50 | -20.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.